Publications
- Individually determined dosing of filgrastim after autologous peripheral stem cell transplantation in patients with malignant lymphoma -results of a prospective multicentre controlled trial2006 | First Faculty of Medicine, Faculty of Physical Education and Sport, Third Faculty of Medicine
- Risk factors for malignant lymphoproliferation in Sjögren´s syndrome2007 | First Faculty of Medicine
- Cefepime as an empiric treatment of febrile neutropenia in patients after high dose therapy and autologous stem cell transplantation2006 | First Faculty of Medicine
- The individually deferred dosing of G-CSF after autologous stem cell transplantation in patients with malignant lymphoma - results of multicentre randomised trialPublication without faculty affiliation
- Individuálně oddálené podávání filgrastimu po autologní transplantaci krvetvorných buněk u nemocných s maligním lymfomem - výsledky prospektivní randomizované multicentrické studie.Publication without faculty affiliation
- PET findings after therapy during folow-up in patients with Hodgkin lymphoma- a retrospective studyPublication without faculty affiliation
- Risk faktors of malignant lymfoproliferace at Sjögren´s syndromePublication without faculty affiliation
- A ''single'' dose of G-CSF after autologous stem cell transplantation in patients with malignant ylmphoma -third interim analysis of multicentre randomized trial comparing standard schedule with delayed application and placebo.Publication without faculty affiliation
Loading network view...